Risk factors for dementia in patients over 65 with diabetes

International Journal of Geriatric Psychiatry

Volumn 26, Issue 7, 2011, Pages 749-757

  Parikh, Niraj M ^a,f   Morgan, Robert O ^b,c   Kunik, Mark E ^b,d,e   Chen, Hua ^a   Aparasu, Rajender R ^a   Yadav, Ravi K ^a   Schulz, Paul E ^b,e   Johnson, Michael L ^a,b  

^a UNIVERSITY OF HOUSTON   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d Education and Clinical Center MIRECC   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f ANALYSIS GROUP   (United States)

Author keywords

dementia; diabetes mellitus; elderly; Veterans

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; COHORT ANALYSIS; DEMENTIA; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE DURATION; DRUG USE; FEMALE; GEOGRAPHIC ORIGIN; GROUPS BY AGE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; UNITED STATES; VETERAN;

AGED; AGED, 80 AND OVER; DEMENTIA; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; VETERANS;

EID: 79954592659     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2604     Document Type: Article

References (35)

1. Arvanitakis Z, Wilson R, Bienias J, Evans D, Bennett D., 2004. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61: 661.
2. Boston PF, Dennis MS, Jagger C., 1999. Factors associated with vascular dementia in an elderly community population. Int J Geriatr Psychiatry 14: 761-766. (Pubitemid 29450289)
3. Bruce D, Davis W, Casey G, et al,. 2008. Predictors of cognitive decline in older people with diabetes. Diabetes Care. 31: 2103-2107.
4. Carro E, Torres-Aleman I., 2004. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. Eur J Pharmacol 490: 127-133. (Pubitemid 38482166)
5. Fillenbaum GG, Peterson B, Welsh-Bohmer KA, Kukull WA, Heyman A., 1998. Progression of Alzheimer's disease in black and white patients: the CERAD experience, part XVI. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 51: 154-158. (Pubitemid 28345376)
6. Hargrave R, Stoeklin M, Haan M, Reed B., 1998. Clinical aspects of Alzheimer's disease in black and white patients. J Natl Med Assoc 90: 78-84. (Pubitemid 128454294)
7. Hayden KM, Zandi PP, Lyketsos CG, et al,. 2006. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 20: 93-100. (Pubitemid 44305908)
8. Hebert R, Lindsay J, Verreault R, et al,. 2000. Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke 31: 1487-1493. (Pubitemid 30437492)
9. Heyman A, Fillenbaum G, Prosnitz B, et al,. 1991. Estimated prevalence of dementia among elderly black and white community residents. Arch Neurol 48: 594.
10. Hofman A, Rocca WA, Brayne C, et al,. 1991. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol 20: 736-748.
11. Hynes D, Koelling K, Stroupe K, et al,. 2007. Veterans' access to and use of Medicare and Veterans Affairs health care. Med Care 45: 214.
12. Jorm AF, Korten AE, Henderson AS., 1987. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76: 465-479. (Pubitemid 17164786)
13. Kreyenbuhl J, Medoff D, Seliger S, Dixon L., 2008. Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetes. Schizophr Res 101: 256-265.
14. Leibson C, Rocca W, Hanson V, et al,. 1997. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 145: 301.
15. Liao Y, Greenlund KJ, Croft JB, Keenan NL, Giles WH., 2009. Factors explaining excess stroke prevalence in the US Stroke Belt. Stroke 40: 3336-3341.
16. Little R, Rubin D., 1989. The analysis of social science data with missing values. Sociol Methods Res 18: 292.
17. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R., 2001. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154: 635-641. (Pubitemid 32888781)
18. Mielke MM, Zandi PP, Sjögren M, Gustafson D, Östling S, Steen B, Skoog I., High cholesterol levels in late life assotiated with a reduced risk of dementia. Neurology 2005; 64 (10): 1689-1695. (Pubitemid 40695799)
19. Miles T, Froehlich T, Bogardus S, Inouye S., 2001. Dementia and race: are there differences between African Americans and Caucasians ? J Am Geriatr Soc 49: 477-484. (Pubitemid 32390885)
20. Ott A, Stolk RP, van Harskamp F, et al,. 1999. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53: 1937-1942.
21. Peila R, Rodriguez BL, Launer LJ., 2002. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 51: 1256-1262. (Pubitemid 34438377)
22. Petersen LA, Pietz K, Woodard LD, Byrne M., 2005. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes. Med Care 43: 61-67. (Pubitemid 40137615)
23. Pope G, Kautter J, Ellis R, et al,. 2004. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev 25: 119-142.
24. Qiu C, de Ronchi D, Fratiglioni L., 2007. The epidemiology of the dementias: an update. Curr opin psychiatry 20: 380.
25. Ritchie K, Kildea D., 1995. Is senile dementia age-related or ageing-related?: evidence from meta-analysis of dementia prevalence in the oldest old. Lancet(British edition) 346: 931-934.
26. Ritchie K, Kildea D, Robine J., 1992. The relationship between age and the prevalence of senile dementia: a meta-analysis of recent data. Int J Epidemiol 21: 763.
27. Roberts RO, Geda YE, Knopman DS, et al,. 2008. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 65: 1066-1073.
28. Schnaider Beeri M, Goldbourt U, Silverman JM, et al,. 2004. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 63: 1902-1907. (Pubitemid 39532388)
29. Shadlen MF, Larson EB, Gibbons L, McCormick WC, Teri L., 1999. Alzheimer's disease symptom severity in blacks and whites. J Am Geriatr Soc 47: 482-486. (Pubitemid 29181377)
30. Stella F, Banzato CE, Gasparetto Sé EV, et al,. 2007. Risk factors for vascular dementia in elderly psychiatric outpatients with preserved cognitive functions. J Neurol Sci 257: 247-249. (Pubitemid 46863435)
31. Wenger NK, Scheidt S, Weber M., 2007. Cardiovascular risk factors, cardiovascular disease, cardiovascular drug therapies, and dementia/cognitive dysfunction: how do the pieces of the puzzle fit together ? Am J Geriatr Cardiol 16: 133-135.
32. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K., 2005. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64: 277-281.
33. Wolozin B, Wang S, Li N, et al,. 2007. Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med 5: 20.
34. Xu W, Qiu C, Winblad B, Fratiglioni L., 2007. The effect of borderline diabetes on the risk of dementia and Alzheimer's disease. Diabetes 56: 211-216.
35. Yano E, Simon B, Canelo I, Mittman B, Rubenstein L., 2000. VHA survey of primary care practices (technical monograph 00-MC12). Washington, DC; Department of Veterans Affairs.